Patent ID: 6355649
Filing Date: 2002-03-12
Classification: A61K,A61Q,Y10S

Abstract:
A method of treating seborrhea comprising orally administering to a person in need of such treatment a 5&agr;-reductase 2 inhibitor of structural formula I or a pharmaceutically acceptable salt thereof wherein:R1 is hydrogen, methyl or ethyl; R2 is a hydrocarbon radical selected from straight and branched chain alkyl of from 1-12 carbons or monocyclic aryl optionally containing 1 or more lower alkyl substituents of from 1-2 carbon atoms and/or 1 or more halogen (Cl, F or Br) substituents; Râ€² is hydrogen or methyl; Râ€³ is hydrogen or &bgr;-methyl; and Râ€²â€³ is hydrogen, &agr;-methyl or &bgr;-methyl; in a dosage amount from about 0.01 to 3.0 mg/day.